nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A general procedure for the enantioselective synthesis of the minor tobacco alkaloids nornicotine, anabasine, and anatabine
|
Ayers, Joshua T. |
|
2005 |
7 |
3 |
p. E752-E758 |
artikel |
2 |
A new equivalence based metric for predictive check to qualify mixed-effects models
|
Jadhav, Pravin R. |
|
2005 |
7 |
3 |
p. E523-E531 |
artikel |
3 |
Anion-induced water flux as drug release mechanism through cationic Eudragit RS 30D film coatings
|
Wagner, Karl G. |
|
2005 |
7 |
3 |
p. E668-E677 |
artikel |
4 |
Anion-induced water flux as drug release mechanism through cationic Eudragit RS 30D film coatings
|
Wagner, Karl G. |
|
|
7 |
3 |
|
artikel |
5 |
Impact of pharmacometrics on drug approval and labeling decisions: A survey of 42 new drug applications
|
Bhattaram, Venkatesh A. |
|
2005 |
7 |
3 |
p. E503-E512 |
artikel |
6 |
In vivo microdialysis for PK and PD studies of anticancer drugs
|
Zhou, Qingyu |
|
2005 |
7 |
3 |
p. E659-E667 |
artikel |
7 |
It’s time
|
Smith, Brian P. |
|
2005 |
7 |
3 |
p. E655-E658 |
artikel |
8 |
Kappa opioid antagonists: Past successes and future prospects
|
Metcalf, Matthew D. |
|
2005 |
7 |
3 |
p. E704-E722 |
artikel |
9 |
k Opioids as potential treatments for stimulant dependence
|
Prisinzano, Thomas E. |
|
2005 |
7 |
3 |
p. E592-E599 |
artikel |
10 |
Lung microdialysis—A powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract (mini-review)
|
Zeitlinger, Markus |
|
2005 |
7 |
3 |
p. E600-E608 |
artikel |
11 |
Lung microdialysis—A powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract (mini-review)
|
Zeitlinger, Markus |
|
|
7 |
3 |
|
artikel |
12 |
Microdialysis of large molecules
|
Clough, Geraldine F. |
|
2005 |
7 |
3 |
p. E686-E692 |
artikel |
13 |
Microdialysis of large molecules
|
Clough, Geraldine F. |
|
|
7 |
3 |
|
artikel |
14 |
Model-based development of gemcabene, a new lipid-altering agent
|
Mandema, Jaap W. |
|
2005 |
7 |
3 |
p. E513-E522 |
artikel |
15 |
Molecular modeling of mono- and bis-quaternary ammonium salts as ligands at the α4β2 nicotinic acetylcholine receptor subtype using nonlinear techniques
|
Ayers, Joshua T. |
|
2005 |
7 |
3 |
p. E678-E685 |
artikel |
16 |
Molecular modeling of mono- and bis-quaternary ammonium salts as ligands at the α4β2 nicotinic acetylcholine receptor subtype using nonlinear techniques
|
Ayers, Joshua T. |
|
|
7 |
3 |
p. E678-E685 |
artikel |
17 |
Mucosal delivery of bacterial antigens and CpG oligonucleotides formulated in biphasic lipid vesicles in pigs
|
Alcon, Valeria |
|
2005 |
7 |
3 |
p. E566-E571 |
artikel |
18 |
Mucosal delivery of bacterial antigens and CpG oligonucleotides formulated in biphasic lipid vesicles in pigs
|
Alcon, Valeria |
|
|
7 |
3 |
|
artikel |
19 |
Mu opioid receptor regulation and opiate responsiveness
|
Raehal, Kirsten M. |
|
2005 |
7 |
3 |
p. E587-E591 |
artikel |
20 |
Opioid peptide-derived analgesics
|
Schiller, Peter W. |
|
2005 |
7 |
3 |
p. E560-E565 |
artikel |
21 |
Opioid peptide-derived analgesics
|
Schiller, Peter W. |
|
|
7 |
3 |
|
artikel |
22 |
Patent issues in drug development: Perspectives of a pharmaceutical scientist-attorney
|
Melethil, Srikumaran |
|
2005 |
7 |
3 |
p. E723-E727 |
artikel |
23 |
Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation
|
Piotrovsky, Vladimir |
|
2005 |
7 |
3 |
p. E609-E624 |
artikel |
24 |
Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation
|
Piotrovsky, Vladimir |
|
|
7 |
3 |
|
artikel |
25 |
Pharmacokinetics/pharmacodynamics and the stages of drug development: Role of modeling and simulation
|
Chien, Jenny Y. |
|
2005 |
7 |
3 |
p. E544-E559 |
artikel |
26 |
Population pharmacokinetics of recombinant factor XIII in cynomolgus monkeys
|
Dodds, Michael G. |
|
2005 |
7 |
3 |
p. E693-E703 |
artikel |
27 |
Recognition of psychostimulants, antidepressants, and other inhibitors of synaptic neurotransmitter uptake by the plasma membrane monoamine transporters
|
Surratt, Christopher K. |
|
2005 |
7 |
3 |
p. E739-E751 |
artikel |
28 |
Regulation of monoamine transporters: Influence of psychostimulants and therapeutic antidepressants
|
Jayanthi, Lankupalle D. |
|
2005 |
7 |
3 |
p. E728-E738 |
artikel |
29 |
RETRACTED ARTICLE: Recent advances for the treatment of cocaine abuse: Central nervous system immunopharmacotherapy
|
Dickerson, Tobin J. |
|
2005 |
7 |
3 |
p. E579-E586 |
artikel |
30 |
RNAi-directed inhibition of DC-SIGN by dendritic cells: Prospects for HIV-1 therapy
|
Nair, Madhavan P. N. |
|
2005 |
7 |
3 |
p. E572-E578 |
artikel |
31 |
The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids
|
Pertwee, Roger G. |
|
2005 |
7 |
3 |
p. E625-E654 |
artikel |
32 |
The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids
|
Pertwee, Roger G. |
|
|
7 |
3 |
|
artikel |
33 |
Toward the prediction of CNS drug-effect profiles in physiological and pathological conditions using microdialysis and mechanism-based pharmacokinetic-pharmacodynamic modeling
|
Lange, Elizabeth C. M. de |
|
2005 |
7 |
3 |
p. E532-E543 |
artikel |
34 |
Toward the prediction of CNS drug-effect profiles in physiological and pathological conditions using microdialysis and mechanism-based pharmacokinetic-pharmacodynamic modeling
|
de Lange, Elizabeth C. M. |
|
|
7 |
3 |
|
artikel |